Individualized Dosing of Therapeutic Monoclonal Antibodies:
A Changing Treatment
Paradigm?
Identification of Peptide Mimotope Ligands for Natalizumab
A Phase I Study of Escalated dose subcutaneous Alemtuzumab given weekly with Rituximab in Relapsed chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma
A General Process for the Development of Peptide-based Immunoassays for Monoclonal Antibodies